With box warnings

Without box warnings

Branded

Generic

3 results

mycophenolic acid
(mycophenilic acid)
Archis Pharma LLC
Usage: Mycophenolic acid delayed-release tablets are indicated for the prophylaxis of organ rejection in kidney transplant patients, both adult and pediatric (5 years and older), in combination with cyclosporine and corticosteroids. Use interchangeably with mycophenolate mofetil is not recommended without physician supervision.
mycophenolic acid
(MYCOPHENOLIC ACID)
Ascend Laboratories, LLC
Usage: Mycophenolic acid delayed-release tablets are indicated for the prophylaxis of organ rejection in adults and pediatric patients (5 years and older) following kidney transplant, to be used in combination with cyclosporine and corticosteroids. Interchangeability with mycophenolate mofetil requires physician supervision due to absorption differences.
myfortic
(mycophenolic acid)
Novartis Pharmaceuticals Corporation
Usage: Myfortic (mycophenolic acid) is indicated for the prophylaxis of organ rejection in adult and pediatric kidney transplant patients (5 years and older, at least 6 months post-transplant), to be used alongside cyclosporine and corticosteroids. Use caution as it should not be interchangeable with mycophenolate mofetil without physician supervision.

Antimetabolite Immunosuppressant class drugs

mycophenolic acid